-
公开(公告)号:US20190211339A1
公开(公告)日:2019-07-11
申请号:US15768424
申请日:2016-10-17
发明人: Suneet Agarwal , Diane Moon , Baris Boyraz , Matthew Segal
IPC分类号: C12N15/113 , C07K16/40 , A61K31/7052 , A61K31/7036 , A61K31/713 , A61K45/06 , A61K38/00
CPC分类号: C12N15/1137 , A61K31/7036 , A61K31/7048 , A61K31/7052 , A61K31/713 , A61K38/005 , A61K45/06 , C07K16/40 , C07K2319/00 , C07K2319/80 , C12N9/1241 , C12N9/16 , C12N2310/11 , C12N2310/122 , C12N2310/14 , C12N2310/20 , C12Q1/6883 , C12Q1/6886 , C12Q2600/106 , C12Q2600/136 , C12Q2600/156 , C12Q2600/158 , C12Y207/07019 , C12Y301/13004 , G01N33/573 , G01N33/6893 , G01N2333/91245 , G01N2500/10 , A61K2300/00
摘要: The disclosure relates to treating and diagnosing telomere diseases, and methods of screening agents for treating and diagnosing telomere diseases.
-
公开(公告)号:US20140363876A1
公开(公告)日:2014-12-11
申请号:US14471649
申请日:2014-08-28
申请人: CELLSCRIPT, LLC
发明人: Jerome Jendrisak , Ronald Meis , Gary Dahl
IPC分类号: C12P19/34
CPC分类号: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
摘要: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
-
公开(公告)号:US20070281336A1
公开(公告)日:2007-12-06
申请号:US11787352
申请日:2007-04-16
申请人: Jerome Jendrisak , Ronald Meis , Gary Dahl
发明人: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC分类号: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
摘要: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. The invention is used to obtain novel compositions of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA for a variety of research, therapeutic, and commercial applications. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, such as RNA synthesized in vitro or obtained from a biological source, including prokaryotic mRNA that is in a mixture with other prokaryotic and/or eukaryotic nucleic acids. The method for capturing modified-nucleotide-capped RNA also provides methods and kits for obtaining only type-specific or condition-specific modified-nucleotide-capped RNA by cap-dependent subtraction of that portion of the captured modified-nucleotide-capped RNA in cells of one type or condition that is the same as RNA in cells of another type or condition. The invention further provides methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
摘要翻译: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 本发明用于获得这种经修饰的核苷酸封端RNA分子的新组合物。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于体外生产具有修饰的帽核苷酸的5'上限的RNA,并且通过体外或体内翻译这些经修饰的核苷酸封端的RNA进行多种研究,体外或体内产生多肽 ,治疗和商业应用。 本发明还提供用于捕获或分离未包封的RNA的方法和试剂盒,其包含初级RNA转录物或具有5'-二磷酸的RNA,例如在体外合成或从生物来源获得的RNA,包括与其他原核生物混合的原核mRNA 和/或真核的核酸。 用于捕获修饰的核苷酸加帽的RNA的方法还提供用于仅通过Cap依赖性减去细胞中捕获的修饰核苷酸加帽的RNA的那部分获得仅特定类型或条件特异性修饰的核苷酸加帽的RNA的方法和试剂盒 与另一类型或病症细胞中的RNA相同的一种类型或病症。 本发明还提供了使用封端酶系统和修饰的帽核苷酸标记未封端RNA的方法和试剂盒,其包含具有可检测染料或酶部分的具有5'-二磷酸的初级RNA转录物或RNA。
-
4.
公开(公告)号:US20230183770A1
公开(公告)日:2023-06-15
申请号:US17931352
申请日:2022-09-12
申请人: ImmunityBio, Inc.
发明人: Brett Morimoto , Kayvan Niazi , Annie Shin , Lise Geissert , Philip T. Liu
CPC分类号: C12P19/34 , C12N9/1247 , C12N9/1241 , C12Y207/07019
摘要: A method for the production of proteins used in the in vitro transcription (IVT) of messenger RNA (mRNA), wherein the proteins are evaluated for purity and efficacy by the efficiency with which mRNA synthetically derived therefrom, subsequently transfects cells and produces encoded proteins.
-
公开(公告)号:US20180142275A1
公开(公告)日:2018-05-24
申请号:US15570195
申请日:2016-05-02
申请人: CureVac AG
IPC分类号: C12P19/34 , C12N11/06 , C12N11/14 , C12N9/12 , C12N15/113 , C12Q1/6806 , C12N15/10
CPC分类号: C12P19/34 , C12N9/1241 , C12N11/02 , C12N11/06 , C12N11/14 , C12N15/1006 , C12N15/113 , C12Q1/6806 , C12Y207/07019 , Y02P20/588
摘要: The present invention relates to an immobilized poly(N)polymerase (PNP), methods of producing said PNP and uses thereof. Further disclosed is an enzyme reactor and kit comprising the PNP for producing polynucleotidylated ribonucleic acid poly(N)RNA)molecules which are useful in gene therapy, immunotherapy, protein replacement therapy and/or vaccination.
-
公开(公告)号:US20140363851A1
公开(公告)日:2014-12-11
申请号:US14444440
申请日:2014-07-28
IPC分类号: C12P19/34
CPC分类号: C12Q1/6844 , C12N9/1241 , C12N9/1264 , C12P19/34 , C12Q1/6806 , C12Y207/07019 , C12Y207/07031 , Y02P20/582 , C12Q2525/186
摘要: The invention provides improved methods for synthesizing polynucleotides, such as DNA and RNA, using enzymes and specially designed nucleotide analogs. Using the methods of the invention, specific sequences of polynucleotides can be synthesized de novo, base by base, in an aqueous environment, without the use of a nucleic acid template. Because the nucleotide analogs have an unmodified 3′ OH, i.e., as found in “natural” deoxyribose and ribose molecules, the analogs result in natural polynucleotides suitable for incorporation into biological systems.
-
公开(公告)号:US09115380B2
公开(公告)日:2015-08-25
申请号:US14666805
申请日:2015-03-24
申请人: CELLSCRIPT, LLC
发明人: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC分类号: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
摘要: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
摘要翻译: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
公开(公告)号:US20150191760A1
公开(公告)日:2015-07-09
申请号:US14666805
申请日:2015-03-24
申请人: CELLSCRIPT, LLC
发明人: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC分类号: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
摘要: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
摘要翻译: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
公开(公告)号:US08846348B2
公开(公告)日:2014-09-30
申请号:US14185384
申请日:2014-02-20
申请人: CellScript, LLC
发明人: Jerome Jendrisak , Ronald Meis , Gary Dahl
CPC分类号: C12P19/34 , C12N9/1007 , C12N9/1241 , C12N15/1072 , C12N15/1075 , C12N15/1096 , C12N15/111 , C12N15/113 , C12N2310/317 , C12N2320/51 , C12Y201/01056 , C12Y201/01057 , C12Y207/07019 , C12Y207/0705
摘要: The present invention relates to kits and methods for efficiently generating 5′ capped RNA having a modified cap nucleotide and for use of such modified-nucleotide-capped RNA molecules. In particular, the present invention provides kits and methods for capping RNA using a modified cap nucleotide and a capping enzyme system, such as poxvirus capping enzyme. The present invention finds use for in vitro production of 5′-capped RNA having a modified cap nucleotide and for in vitro or in vivo production of polypeptides by in vitro or in vivo translation of such modified-nucleotide-capped RNA. The invention also provides methods and kits for capturing or isolating uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate, and methods and kits for using a capping enzyme system and modified cap nucleotides for labeling uncapped RNA comprising primary RNA transcripts or RNA having a 5′-diphosphate with detectable dye or enzyme moieties.
摘要翻译: 本发明涉及用于有效产生具有修饰的帽核苷酸的5'封端RNA并用于这种经修饰的核苷酸封端的RNA分子的试剂盒和方法。 特别地,本发明提供了使用修饰的帽核苷酸和封端酶系统(例如痘病毒覆盖酶)对RNA进行封端的试剂盒和方法。 本发明用于通过体外或体内翻译这些经修饰的核苷酸加帽的RNA来体外生产具有修饰的帽核苷酸的5'-加帽的RNA,以及体外或体内产生多肽。 本发明还提供用于捕获或分离包含初级RNA转录物或具有5'-二磷酸的RNA的未封端RNA的方法和试剂盒,以及使用封端酶系统和修饰的帽核苷酸用于标记包含初级RNA转录物或RNA的未加帽RNA的方法和试剂盒 具有可检测的染料或酶部分的5'-二磷酸酯。
-
公开(公告)号:US06696546B1
公开(公告)日:2004-02-24
申请号:US09707263
申请日:2000-11-06
申请人: Gareth Lane Bond , James L. Manley , Carol Prives
发明人: Gareth Lane Bond , James L. Manley , Carol Prives
IPC分类号: C07K1446
CPC分类号: C12N9/1241 , A61K38/00 , C12Y207/07019
摘要: The present invention provides purified and synthetic peptides comprising the amino acid sequences shown in SEQ ID NO: 1 and SEQ ID NO: 3. The invention also provides pharmaceutical compositions comprising the peptides and methods of killing dividing cells and treating abnormalities and tumors in a subject using the peptides.
摘要翻译: 本发明提供了包含SEQ ID NO:1和SEQ ID NO:3所示氨基酸序列的纯化和合成的肽。本发明还提供包含肽的药物组合物和杀死分裂细胞的方法以及治疗受试者的异常和肿瘤 使用肽。
-
-
-
-
-
-
-
-
-